Request a quote

News & Events

News

Events

News

Corporate

Pioneering Gene Therapy: uBriGene as Your Strategic Partner

August 7, 2024

uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, An AAV-based Gene Therapy

News

Technology

Educational webinar series by uBriGene

April 24, 2024

uBriGene's Educational Webinar Series on ATMPs Development and Manufacturing

News

Technology

Cell Therapy Potency launching

March 13, 2024

New Service Launch - Cell Therapy Potency Analytical Development and GMP Testing

News

Technology

Success factors for cell therapy

February 1, 2024

Top 3 success factors for cell therapy potency assays

News

Corporate

Mustang Bio transaction completion

July 31, 2023

uBriGene (Boston) Biosciences completed the transaction with Mustang Bio, Inc. (Nasdaq: MBIO)

News

Corporate

Targets North American growth with major acquisition

May 18, 2023

Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition

News

Corporate

20 million USD Series C+ round closed

April 20, 2023

uBriGene Biosciences Inc. closes 150 million CNY (20 million USD) Series C+ round

News

Corporate

Completion of series C round funding

December 23, 2022

uBriGene Biosciences completes several hundred million yuan Series C round funding

News

Technology

IND application approval

December 23, 2022

Correcting visual impairment: VGR-R01 project IND application accepted by Center for Drug Evaluation

News

Technology

Clinical Application for Hemophilia B accepted

April 21, 2022

Assisted Clinical Application of Gene Therapy for Hemophilia B of Vitalgen Accepted by NMPA

News

Technology

Clinical Application in Ophthalmology passed

January 27, 2022

Assisted Clinical Application of Gene Therapy in Ophthalmology of Innostellar Accepted by NMPA

Load More News

Event

Corporate

uBriGene to Showcase Innovations at ASH 2024

December 7, 2024 | San Diego, CA, USA

mRNA-LNP Mediated CAR-T Manufacturing from uBriGene Set to Shine at ASH 2024

Event

Corporate

uBriGene's breakthroughs at the 12th mRNA Health

November 12, 2024 | Boston, MA, USA

Breakthrough RNA Therapies From uBriGene Featured at the 12th International mRNA Health Conference

Event

Corporate

Discover uBriGene's advancements at the Advanced Therapies 2024

November 12, 2024 | Pennsylvania, PA, USA

Discover uBriGene’s Innovations at The Advanced Therapies Congress 2024!

Event

Corporate

uBriGene highlights research at Oncolytic conference

October 27, 2024 | Rotterdam, Netherland

uBriGene Highlights Research at the 16th Oncolytic Virotherapy Conference, Rotterdam

Event

Corporate

Meet uBriGene at Meeting on the Mesa

October 7, 2024 | Phoenix, AZ, USA

Meet uBriGene at the Cell & Gene Meeting on the Mesa 2024

Event

Corporate

uBriGene at the 9th CAR-TCR summit

September 17, 2024 | Boston, MA, USA

Lunch & learn with uBriGene at the 9th CAR-TCR summit

Event

Corporate

Meet uBriGene at BIO2024

June 3, 2024 | San Diego, CA, USA

Join uBriGene Biosciences to Discover the Future of Biotech at BIO San Diego Jun 03 - 06!

Event

Corporate

uBrigene's showcase at ISCT2024

May 29, 2024 | Vancouver, BC, Canada

uBriGene's showcase at ISCT2024 Vancouver May 29 - Jun 1

Event

Corporate

uBriGene exhibits at ASGCT2024

May 7, 2024 | Baltimore, MD, USA

uBriGene will exhibit at ASGCT2024 this May 7 – 11 in Baltimore

Load More Events